195 related articles for article (PubMed ID: 23625113)
1. Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension.
Schwieler JH; Kahan T; Wallén NH; Nussberger J; Hjemdahl P
J Hypertens; 2013 Aug; 31(8):1676-82. PubMed ID: 23625113
[TBL] [Abstract][Full Text] [Related]
2. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
3. A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
Leu HB; Charng MJ; Ding PY
Jpn Heart J; 2004 Jul; 45(4):623-35. PubMed ID: 15353873
[TBL] [Abstract][Full Text] [Related]
4. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
[TBL] [Abstract][Full Text] [Related]
5. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients.
Azizi M; Linhart A; Alexander J; Goldberg A; Menten J; Sweet C; Ménard J
J Hypertens; 2000 Aug; 18(8):1139-47. PubMed ID: 10954007
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.
Dorresteijn JA; Schrover IM; Visseren FL; Scheffer PG; Oey PL; Danser AH; Spiering W
J Hypertens; 2013 Feb; 31(2):393-403. PubMed ID: 23235355
[TBL] [Abstract][Full Text] [Related]
8. Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.
Remková A; Kratochvíl'ová H; Durina J
J Hum Hypertens; 2008 May; 22(5):338-45. PubMed ID: 18305548
[TBL] [Abstract][Full Text] [Related]
9. Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial.
Li-Saw-Hee FL; Beevers DG; Lip GY
Int J Cardiol; 2001 May; 78(3):241-6. PubMed ID: 11376827
[TBL] [Abstract][Full Text] [Related]
10. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Renke M; Tylicki L; Rutkowski P; Rutkowski B
Scand J Urol Nephrol; 2004; 38(5):427-33. PubMed ID: 15764256
[TBL] [Abstract][Full Text] [Related]
11. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Avanza AC; El Aouar LM; Mill JG
Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
[TBL] [Abstract][Full Text] [Related]
12. Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.
Jilma B; Li-Saw-Hee FL; Wagner OF; Beevers DG; Lip GY
Clin Sci (Lond); 2002 Aug; 103(2):131-6. PubMed ID: 12149103
[TBL] [Abstract][Full Text] [Related]
13. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation during exercise is not attenuated by inhibition of the renin angiotensin system: the role of physical activity.
Kahan T; Schwieler JH; Wallén H; Nussberger J; Hjemdahl P
J Hypertens; 2013 Oct; 31(10):2103-4. PubMed ID: 24107740
[No Abstract] [Full Text] [Related]
15. Platelet activation during exercise is not attenuated by inhibition of the renin-angiotensin system: the role of physical activity.
Petidis K; Grammatiki M; Doumas M
J Hypertens; 2013 Oct; 31(10):2103. PubMed ID: 24107739
[No Abstract] [Full Text] [Related]
16. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
17. [Effect of enalapril maleate on vascular endothelial function and platelet-endothelial interactions in patients with essential hypertension].
Iakovlev VM; Semenkin AA; Iudin SM; Nazarov AG; Kudriashov IL; Potapov VV; Korennova OIu; Il'iunykh LN
Ter Arkh; 2000; 72(1):40-4. PubMed ID: 10687205
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
19. Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension.
Ekholm M; Jekell A; Wallén NH; Gigante B; Kahan T
J Cardiovasc Pharmacol; 2018 Apr; 71(4):240-247. PubMed ID: 29389738
[TBL] [Abstract][Full Text] [Related]
20. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
Nielsen S; Dollerup J; Nielsen B; Jensen HA; Mogensen CE
Nephrol Dial Transplant; 1997; 12 Suppl 2():19-23. PubMed ID: 9269694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
